Journal list Promote Sponsor
verified SJR 0,32 · Q3 • database Scopus / SJR & Web of Science indexed
Expert Review of Ophthalmology
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q3 — Biomedical Engineering lock Subscription

Expert Review of Ophthalmology

Expert Review of Ophthalmology is a journal indexed in SJR in Biomedical Engineering and Ophthalmology with an H index of 33. It has a price of 4000 €. It has an SJR impact factor of 0,32 and it has a best quartile of Q3. It has an SJR impact factor of 0,32.

ISSN: 1746-9899
Publisher: Taylor and Francis Ltd.
Category: Biomedical Engineering
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,32 Q3
H-index 33
Acceptance rate pie_chart
37%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
4.000 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,32

H-index

33

Docs (year)

44

Docs 3y

140

Total refs

3695

Cites 3y

123

Citable 3y

118

Cites/Doc 2y

0.83

Ref/Doc

83.98

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Brimonidine purite solution for open-angle glaucoma or ocular hypertension

View more

World Ophthalmology Congress 2008 in Hong Kong

View more

Diagnosis and treatment of giant cell arteritis

View more

Deep anterior lamellar keratoplasty: must we really bare Descemet's membrane?

View more

Current techniques to accurately measure anti-retinal autoantibodies

View more

Current medical and surgical therapeutic approaches to cystoid macular edema in uveitis

View more

Current clinical management of ocular tuberculosis

View more

Corrective techniques and future directions for treatment of residual refractive error following cataract surgery

View more

Complications in endothelial keratoplasty

View more

Combination therapy for ocular and tumor angiogenesis

View more

Clinical management of infectious contact lens complications: from antibiotics to quorum-sensing inhibitors

View more

Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration

View more
SHOW MORE ARTICLES

Brinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertension

View more

A focus on the imaging of the retina

View more

Biomarkers of primary open-angle glaucoma

View more

Biodegradable collagen matrix implant for trabeculectomy

View more

Bimatoprost for glaucoma therapy: pharmacology, clinical efficacy and controversy

View more

Big-bubble keratoplasty

View more

Bevacizumab in age-related macular degeneration: why an off-label treatment is the preferred therapy?

View more

Autoregulation of optic nerve head blood flow and its role in open-angle glaucoma

View more

Anti-VEGF agents in the treatment of neovascular AMD

View more

Anecortave acetate in the treatment of age-related macular degeneration

View more

Alternative anti-VEGF treatment regimens in exudative age-related macular degeneration

View more

Advances in the management of retinopathy of prematurity

View more

FAQs